Preliminary scientific tests show conolidine may well inhibit unique ion channels, decreasing neuronal excitability and limiting soreness signals. This mechanism is particularly suitable in neuropathic ache, where irregular signaling leads to persistent pain. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to soreness https://johnt738kbr3.activoblog.com/profile